Time of COVID-19 vaccines authorisation in the EU

Timeline of COVID-19 vaccines authorisations in the EU

The rolling review has reduced the timeline leading up to and including the conditional marketing authorisation. Altogether, these efforts have led to record time in which the vaccines were authorised in the EU as shown in Figure 4: 21 days between Pfizer-BioNTech’s application and the EU’s issuance of the CMA, 36 days for Moderna, 17 days for AstraZeneca and 23 days for Janssen, compared to the standard EU’s review timeline of 210 working days.


Related Articles

Be the first to write a comment.

Leave a Reply

EPRS Logo
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.